Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “Chimerism”
Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
ClinicalTrials.gov study NCT07075523. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa
ClinicalTrials.gov study NCT00987142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy
ClinicalTrials.gov study NCT06926985. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome
ClinicalTrials.gov study NCT05085431. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies
ClinicalTrials.gov study NCT05105867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies
ClinicalTrials.gov study NCT04796688. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
ClinicalTrials.gov study NCT02937844. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05336383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
ClinicalTrials.gov study NCT01372228. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies
ClinicalTrials.gov study NCT07345780. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy
ClinicalTrials.gov study NCT05349266. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma
ClinicalTrials.gov study NCT03118180. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
ClinicalTrials.gov study NCT02959151. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
ClinicalTrials.gov study NCT04107142. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
ClinicalTrials.gov study NCT05993611. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
ClinicalTrials.gov study NCT06652633. IPD Sharing: NO. Countries: 3. Publications: 0.
Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell Malignancies
ClinicalTrials.gov study NCT04007978. IPD Sharing: NO. Countries: 1. Publications: 0.
Chimeric Switch Receptor Modified T Cells for Patients With PD-L1+ Recurrent or Metastatic Malignant Tumors
ClinicalTrials.gov study NCT02930967. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
ClinicalTrials.gov study NCT05429905. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases
ClinicalTrials.gov study NCT07392528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.